Taking your company public through an IPO is a crucial step, presenting a unique opportunity to benefit both your business and its investors. Explore the Nasdaq IPO Academy, a program tailored to ...

Some small IPOs are tentatively scheduled for the short holiday week ahead. Space and defense contractor Karman Holdings ...

Trust is the foundation of any successful partner ecosystem. Transparent KPIs, frequent communication and recognition ...

Gemini’s reported fresh IPO plans come as crypto asset manager Bitwise predicted that at least five “crypto unicorns” would seek a public listing in 2025. It named Circle, Figure and Kraken as ...

MTSR is seeking a well above-range valuation at IPO and will face intense competition from major pharmaceutical companies, even assuming its lead program is approved. I’m neutral (hold ...

The heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public in a challenging market for ...

Obesity biotech Aardvark eyes IPO as Ascentage makes $126M Nasdaq debut ... and considering the potential of several more clinical program launches was what spurred the determination that, at ...

The Bally’s Chicago IPO complies with our obligations under ... In a preliminary prospectus on the offering, Bally’s cautioned that the program “may result in lawsuits against us and the ...

Australian MedTech company Ceretas has successfully secured $1 million in seed funding to advance its low-cost, portable and non-invasive ultrasound ...

An ongoing Phase 3 clinical program for olverembatinib is enrolling ... bring Ascentage up to $1.2 billion more, according to the IPO filing. The next drug in Ascentage’s pipeline is lisaftoclax ...

RWA remains one of the strongest narratives and a real use case for older chains. As the meme token frenzy shows signs of ...